Outcomes among adult recipients of CD19 CAR T-cell therapy for Burkitt lymphoma

被引：0
|
作者：
Samples, Laura S.
Sadrzadeh, Hossein
Frigault, Matthew J.
Jacobson, Caron Alyce
Hamadani, Mehdi
Gurumurthi, Ashwath
Strati, Paolo
Shouval, Roni
Riedell, Peter A.
Dahiya, Saurabh
Yared, Jean
Jain, Michael D.
Locke, Frederick L.
Leslie, Lori Ann
Epperla, Narendranath
Ghosh, Monalisa
Skarbnik, Alan
Hill, Brian T.
Kamdar, Manali K.
Shadman, Mazyar
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[2] Boston Univ, Med Ctr, Boston, MA USA
[3] Massachusetts Gen Hosp, Boston, MA USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Med Coll Wisconsin, Milwaukee, WI USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[8] Mem Sloan Kettering Canc Ctr, New York, NY USA
[9] Univ Chicago, Med Ctr, Chicago, IL USA
[10] Stanford Canc Ctr GI Surg Oncol, Stanford, CA USA
[11] Univ Maryland, Baltimore, MD USA
[12] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[13] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[14] John Theurer Canc Ctr, Hackensack, NJ USA
[15] Ohio State Univ, Columbus, OH USA
[16] Univ Michigan, Hlth Management Res Ctr, Ann Arbor, MI USA
[17] Novant Hlth Canc Inst, Charlotte, NC USA
[18] Cleveland Clin, Cleveland, OH USA
[19] Univ Colorado Hosp, Aurora, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7571
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experience
    Seitter, Samantha J.
    McClelland, Paul H.
    Ahlman, Mark A.
    Goff, Stephanie L.
    Yang, James C.
    McIntyre, Lori
    Rosenberg, Steven A.
    Kochenderfer, James N.
    Brudno, Jennifer N.
    LEUKEMIA & LYMPHOMA, 2022, 63 (10) : 2469 - 2473
  • [22] The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell Therapy
    Jain, Michael D.
    Faramand, Rawan
    Staedtke, Verena
    Bai, Renyuan
    Lee, Sae Bom
    Kotani, Hiroshi
    Reid, Kayla
    Spitler, Kristen
    Chavez, Julio
    Shah, Bijal
    Bachmeier, Christina A.
    Dam, Marian
    Brandjes, Brigett
    Gonzalez, Ricardo J.
    Mullinax, John E.
    Wang, Xuefeng
    Hussaini, Mohammad
    Locke, Frederick L.
    Davila, Marco L.
    BLOOD, 2019, 134
  • [23] The Mechanisms of Altered Blood-Brain Barrier Permeability in CD19 CAR T-Cell Recipients
    Pinto, Soniya N.
    Krenciute, Giedre
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [24] SALVAGE THERAPIES AND OUTCOMES OF PATIENTS WITH RELAPSE OF B-ALL AFTER CD19 CAR T-CELL THERAPY
    Friedes, Barbara
    DiNofia, Amanda
    Li, Yimei
    Iannone, Emma
    Rheingold, Susan
    Leahy, Allison Barz
    Wray, Lisa
    Callahan, Colleen
    Baniewicz, Diane
    Liu, Hongyan
    Getz, Kelly
    Aplenc, Richard
    Maude, Shannon
    Grupp, Stephan
    Myers, Regina
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S54 - S54
  • [25] Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
    Liang, Emily C.
    Albittar, Aya
    Huang, Jennifer J.
    Hirayama, Alexandre, V
    Kimble, Erik L.
    Portuguese, Andrew J.
    Chapuis, Aude
    Shadman, Mazyar
    Till, Brian G.
    Cassaday, Ryan D.
    Milano, Filippo
    Kiem, Hans -Peter
    Riddell, Stanley R.
    Turtle, Cameron J.
    Maloney, David G.
    Gauthier, Jordan
    BLOOD ADVANCES, 2023, 7 (22) : 6990 - 7005
  • [26] Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients
    Tu, Sanfang
    Zhou, Lijuan
    Huang, Rui
    Zhou, Xuan
    Yang, Jilong
    He, Yanjie
    Hu, Yuxing
    Zhang, Honghao
    Xie, Xiaoling
    Li, Yuhua
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1437 - 1440
  • [27] TET2 DISRUPTION ENHANCES THE EFFICACY OF CD19 CAR T-CELL THERAPY
    不详
    CANCER DISCOVERY, 2018, 8 (07) : 793 - 793
  • [28] CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Systemic Autoimmune Diseases
    Cingireddy, Ananya Reddy
    Flores, Brianna
    Wuthrich, John
    Cingireddy, Anirudh Reddy
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [29] Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy
    Hsieh, Emily M.
    Myers, Regina M.
    Yates, Bonnie
    Annesley, Colleen
    John, Samuel
    Taraseviciute, Agne
    Steinberg, Seth M.
    Sheppard, Jennifer
    Chung, Perry
    Chen, Lee
    Lee, Daniel W.
    DiNofia, Amanda
    Grupp, Stephan A.
    Verneris, Michael R.
    Laetsch, Theodore W.
    Bhojwani, Deepa
    Brown, Patrick A.
    Pulsipher, Michael A.
    Rheingold, Susan R.
    Gardner, Rebecca A.
    Gore, Lia
    Shah, Nirali N.
    Lamble, Adam J.
    BLOOD ADVANCES, 2022, 6 (17) : 5222 - 5226
  • [30] Prognostic significance of immune reconstitution following CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphoma
    Stock, Sophia
    Bucklein, Veit L.
    Blumenberg, Viktoria
    Magno, Giulia
    Emhardt, Alica-Joana
    Holzem, Alessandra M. E.
    dos Santos, David M. Cordas
    Schmidt, Christian
    Griesshammer, Stefanie
    Frolich, Lisa
    Kobold, Sebastian
    von Bergwelt-Baildon, Michael
    Rejeski, Kai
    Subklewe, Marion
    HEMASPHERE, 2025, 9 (01):
12345